Lorad of Danbury, CT, will show its latest developments in bothscreen-film and digital mammography in its RSNA booth. On theconventional side, Lorad will introduce M-IV, its newest mammographyplatform and successor to M-III (SCAN 10/11/95). M-IV's high
Lorad of Danbury, CT, will show its latest developments in bothscreen-film and digital mammography in its RSNA booth. On theconventional side, Lorad will introduce M-IV, its newest mammographyplatform and successor to M-III (SCAN 10/11/95).
M-IV's high transmission cellular grid system (HTC) improvescontrast in screen-film mammography at an equal or lower radiationdose than conventional systems, according to Hal Kirshner, presidentof Lorad and ThermoTrex Medical. It should prove particularlyuseful for imaging patients with dense breasts, Kirshner said.HTC will be available as an option on M-IV units.
Lorad will also reveal its latest work in full-view digital mammography.The company will show patient images acquired with a system beingused by Dr. Laurie Fajardo at the University of Virginia.
In addition, the company has adapted its StereoLoc prone digitalbreast biopsy technology for its upright mammography systems.Lorad will also display a line of radiographic equipment beingdeveloped for the firm by Bennett X-Ray, its new sister company.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
Multicenter Study Identifies Key Factors Associated with Mammogram-Occult Ipsilateral Breast Cancer
October 9th 2024A symptomatic first breast cancer diagnosis, prevailing breast density at a second breast cancer diagnosis and trabecular thickening on surveillance mammography were linked to mammogram-occult ipsilateral breast cancer, according to new research.
Radiology Experience, Breast Density and Screening Mammography: What New Research Reveals
October 4th 2024In a study looking at the impact of experience and case volume of breast screening radiologists, researchers found that reviewing more than 150 cases per week was necessary to achieve an 80 percent rate of true-positive assessments for malignant calcifications.